Stock WANBURY WANBURY LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Company Wanbury Limited NSE India S.E.

Equities

WANBURY

INE107F01022

Pharmaceuticals

Market Closed - NSE India S.E.
Other stock markets
 07:43:50 2024-05-03 am EDT 		5-day change 1st Jan Change
149.2 INR +1.26% Intraday chart for Wanbury Limited -5.42% +18.37%
Apr. 01 Wanbury Limited Announces Retirement of Narinder Kumar Puri as Independent Director CI
Feb. 21 Wanbury Limited Announces Retirement of Pallavi Prakash Shedge as Independent Director CI

Business Summary

Wanbury Limited is an India-based pharmaceutical company. The Company is engaged in the business of pharmaceutical and related activities, including research. The Company operates through two divisions: the Active Pharmaceutical Ingredients (API) Business and the Domestic Formulations Business. The Company, through the Active Pharmaceutical Ingredients (API) Business, provides Metformin and Sertraline. Metformin is used for the treatment for type 2 diabetes and Sertraline is an anti-depressant. It has approximately 13 API products. It manufactures Metformin with over 8500 tons per year. Its products include Metformin HCL, Metformin DC/SR, Sertraline, Diphenhydramine, Mefenamic Acid, Glucosamine, Methoxsalen and Paroxetine. The Company's subsidiaries include Wanbury Holdings B. V. (Netherland), Wanbury Global FZE (UAE), Ningxia Wanbury Fine Chemicals Co. Ltd. (China) and Cantabria Pharma S. L. (Spain).

Number of employees: 1,582

Sales per Business

INR in Million2022Weight2023Weight Delta
Pharmaceutical
100.0 %
5,112 100.0 % 4,996 100.0 % -2.26%

Sales per region

INR in Million2022Weight2023Weight Delta
International
60.2 %
3,029 59.7 % 2,998 60.2 % -1.01%
India
39.8 %
2,044 40.3 % 1,984 39.8 % -2.94%

Managers

Managers TitleAgeSince
Vinod Verma DFI
 Director of Finance/CFO - 16-04-21
Jitendra J. Gandhi CMP
 Compliance Officer - 15-08-19

Members of the board

Members of the board TitleAgeSince
Chandran K. Sivaram BRD
 Director/Board Member 65 01-01-22
Anupama Vaidya BRD
 Director/Board Member 52 22-03-16
Pravin Dilip Pawar BRD
 Director/Board Member - Nov. 17

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 32,745,498 11,057,717 ( 33.77 %) 0 33.77 %

Shareholders

NameEquities%Valuation
Expert Chemicals (India) Pvt Ltd.
30.56 %
10,005,561 30.56 % 17 M ₹
Kingsbury Investments, Inc.
9.235 %
3,024,000 9.235 % 5 M ₹
Elizabeth Mathew
4.588 %
1,502,483 4.588 % 3 M ₹
AUTHUM INVESTMENT & INFRASTRUCTURE LIMITED
3.863 %
1,265,000 3.863 % 2 M ₹
Bakliwal Fincom Pvt Ltd.
2.819 %
923,077 2.819 % 2 M ₹
Vijay K Choraria
2.819 %
923,077 2.819 % 2 M ₹
Suresh Bhatia
2.349 %
769,230 2.349 % 1 M ₹
Magnum Equifin Pvt Ltd.
1.527 %
500,100 1.527 % 874 550 ₹
Eight Six Advisors Llp East
1.409 %
461,538 1.409 % 807 115 ₹
Varalakshmi Veldi
1.407 %
460,567 1.407 % 805 417 ₹

Company contact information

Wanbury Ltd.

BSEL Techpark, B-Wing, Sector 30-A Opp. Vashi Railway Station

400703, Mumbai

+91 22 6794 2222

http://www.wanbury.com
address Wanbury Limited(WANBURY)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Generic Pharmaceuticals

Sales per region

Sector Generic Pharmaceuticals

1st Jan change Capi.
SUN PHARMACEUTICAL INDUSTRIES LTD. Stock Sun Pharmaceutical Industries Ltd.
+19.98% 43.48B
OTSUKA HOLDINGS CO., LTD. Stock Otsuka Holdings Co., Ltd.
+20.67% 22.65B
SANDOZ GROUP AG Stock Sandoz Group AG
+14.56% 14.73B
CIPLA LIMITED Stock Cipla Limited
+14.32% 13.79B
ZYDUS LIFESCIENCES LIMITED Stock Zydus Lifesciences Limited
+44.72% 12.04B
ONO PHARMACEUTICAL CO., LTD. Stock Ono Pharmaceutical Co., Ltd.
-8.37% 7.08B
THE MEDICINES COMPANY Stock The Medicines Company
-0.05% 6.79B
STADA ARZNEIMITTEL Stock STADA Arzneimittel
-8.87% 5.73B
ASPEN PHARMACARE HOLDINGS LIMITED Stock Aspen Pharmacare Holdings Limited
+11.90% 5.47B
Generic Pharmaceuticals
  1. Stock Market
  2. Equities
  3. WANBURY Stock
  4. WANBURY Stock
  5. Company Wanbury Limited